| Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study A Assiri, JA Al-Tawfiq, AA Al-Rabeeah, FA Al-Rabiah, S Al-Hajjar, ... The Lancet infectious diseases 13 (9), 752-761, 2013 | 1777 | 2013 |
| Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome YM Arabi, Y Mandourah, F Al-Hameed, AA Sindi, GA Almekhlafi, ... American journal of respiratory and critical care medicine 197 (6), 757-767, 2018 | 1308 | 2018 |
| Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection YM Arabi, AA Arifi, HH Balkhy, H Najm, AS Aldawood, A Ghabashi, ... Annals of internal medicine 160 (6), 389-397, 2014 | 722 | 2014 |
| Middle East respiratory syndrome YM Arabi, HH Balkhy, FG Hayden, A Bouchama, T Luke, JK Baillie, ... New England Journal of Medicine 376 (6), 584-594, 2017 | 537 | 2017 |
| Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) YM Arabi, A Harthi, J Hussein, A Bouchama, S Johani, AH Hajeer, ... Infection 43, 495-501, 2015 | 443 | 2015 |
| International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module VD Rosenthal, DG Maki, Y Mehta, H Leblebicioglu, ZA Memish, ... American journal of infection control 42 (9), 942-956, 2014 | 420 | 2014 |
| Rift Valley fever: an uninvited zoonosis in the Arabian peninsula HH Balkhy, ZA Memish International journal of antimicrobial agents 21 (2), 153-157, 2003 | 419 | 2003 |
| Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study M Cotten, SJ Watson, P Kellam, AA Al-Rabeeah, HQ Makhdoom, A Assiri, ... The Lancet 382 (9909), 1993-2002, 2013 | 391 | 2013 |
| Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial YM Arabi, A Alothman, HH Balkhy, A Al-Dawood, S AlJohani, S Al Harbi, ... Trials 19, 1-13, 2018 | 362 | 2018 |
| Tackling antimicrobial resistance in the COVID-19 pandemic H Getahun, I Smith, K Trivedi, S Paulin, HH Balkhy Bulletin of the World Health Organization 98 (7), 442, 2020 | 346 | 2020 |
| Histopathology of Middle East respiratory syndrome coronovirus (MERS‐CoV) infection–clinicopathological and ultrastructural study KO Alsaad, AH Hajeer, M Al Balwi, M Al Moaiqel, N Al Oudah, A Al Ajlan, ... Histopathology 72 (3), 516-524, 2018 | 336 | 2018 |
| Ribavirin and interferon therapy for critically ill patients with middle east respiratory syndrome: a multicenter observational study YM Arabi, S Shalhoub, Y Mandourah, F Al-Hameed, A Al-Omari, ... Clinical infectious diseases 70 (9), 1837-1844, 2020 | 320 | 2020 |
| Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia YM Arabi, AH Hajeer, T Luke, K Raviprakash, H Balkhy, S Johani, ... Emerging infectious diseases 22 (9), 1554, 2016 | 311 | 2016 |
| Antimicrobial resistance: one world, one fight! S Harbarth, HH Balkhy, H Goossens, V Jarlier, J Kluytmans, ... Antimicrobial Resistance and Infection Control 4, 1-15, 2015 | 300 | 2015 |
| Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus M Cotten, SJ Watson, AI Zumla, HQ Makhdoom, AL Palser, SH Ong, ... MBio 5 (1), 10.1128/mbio. 01062-13, 2014 | 288 | 2014 |
| Brucellosis and international travel ZA Memish, HH Balkhy Journal of travel medicine 11 (1), 49-55, 2004 | 285 | 2004 |
| Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol Y Arabi, H Balkhy, AH Hajeer, A Bouchama, FG Hayden, A Al-Omari, ... Springerplus 4, 1-8, 2015 | 251 | 2015 |
| Awareness, attitudes, and practices related to the swine influenza pandemic among the Saudi public HH Balkhy, MA Abolfotouh, RH Al-Hathlool, MA Al-Jumah BMC infectious diseases 10, 1-7, 2010 | 250 | 2010 |
| β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula HM Zowawi, HH Balkhy, TR Walsh, DL Paterson Clinical microbiology reviews 26 (3), 361-380, 2013 | 229 | 2013 |
| Ventriculostomy-associated infections: incidence and risk factors Y Arabi, ZA Memish, HH Balkhy, C Francis, A Ferayan, A Al Shimemeri, ... American journal of infection control 33 (3), 137-143, 2005 | 228 | 2005 |
Yaseen M Arabi, MD, FCCP, FCCM, A...King Saud bin Abdulaziz University for Health SciencesEmail verificata su mngha.med.sa
